Clinical Utility of Serum Pepsinogen Levels as a Screening Test of Atrophic Gastritis
Authors:
Open Access
- 1 June 2008
- journal article
- research article
- Published by Annals of Laboratory Medicine in Annals of Laboratory Medicine
- Vol. 28 (3) , 201-206
Abstract
Chae H, et al. Korean J Lab Med. 2008 Jun;28(3):201-206. https://doi.org/10.3343/kjlm.2008.28.3.201Keywords
This publication has 14 references indexed in Scilit:
- Using serum pepsinogens wisely in a clinical practiceJournal of Digestive Diseases, 2007
- Serum Pepsinogen and Gastric Cancer ScreeningInternal Medicine, 2007
- 2002 Annual Report of the Korea Central Cancer Registry: Based on Registered Data from 139 HospitalsCancer Research and Treatment, 2004
- Pepsinogen A, pepsinogen C, and gastrin as markers of atrophic chronic gastritis in European dyspepticsBritish Journal of Cancer, 2003
- The Serological Gastric Biopsy: a Non-Endoscopical Diagnostic Approach in Management of the Dyspeptic Patient Significance for Primary Care Based on a Survey of the LiteratureScandinavian Journal of Gastroenterology, 2002
- Helicobacter pylori stimulates pepsinogen secretion from isolated human peptic cellsGut, 2002
- Accuracy of screening for gastric cancer using serum pepsinogen concentrationsGut, 1999
- Evaluation of Cutoff Levels for Screening of Gastric Cancer Using Serum Pepsinogens and Distributions of Levels of Serum Pepsinogen I, II and of PG I / PG II Ratios in a Gastric Cancer Case-Control StudyJournal of Epidemiology, 1997
- Helicobacter pylori Infection, Serum Pepsinogen Level and Gastric Cancer: A Case‐Control Study in JapanJapanese Journal of Cancer Research, 1995
- Gastric cancer risk in chronic atrophic gastritis: Statistical calculations of cross‐sectional dataInternational Journal of Cancer, 1985